2+ day, 14+ hour ago  (556+ words) A new series championing analytical scientists in pharma begins with Genentech's rising star Tao Chen is part of a new generation of pharmaceutical analytical scientists helping to reshape how drugs are developed and understood. At Genentech, her work sits at…...

5+ day, 15+ hour ago  (379+ words) Marty Makary's resignation puts the agency under acting leadership, while BMS and Hengrui unveil a multibillion-dollar pipeline deal and GSK lines up a chronic hepatitis B launch in China. FDA commissioner resigns amid HHS leadership changes BMS and Hengrui strike…...

6+ day, 12+ hour ago  (656+ words) Novo Nordisk's Parkinson's cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward MSK develops CAR-T approach inspired by AML patients in long-term remission Precision base editing corrects Dravet syndrome…...

6+ day, 12+ hour ago  (431+ words) How advances in microarray technology are helping bring genomic data closer to real-time clinical decision-making Longstanding scientific and operational gaps in genomic research Turnaround time has been another persistent challenge in the industry. Older microarray systems can take up to…...

1+ week, 2+ day ago  (587+ words) Meg Carr reflects on the key themes from this year's show " from contamination control and AI to flexible facility design In this post-show interview, Carr discusses the pressures shaping biopharma manufacturing today " and what companies need to prioritize as they…...

1+ week, 3+ day ago  (1478+ words) Why understanding titer analytics is key to faster, more reliable biologics and gene therapy development The importance of analytics in biopharma is often overlooked, despite new technologies heavily relying on these processes for innovation. Here, we hear from Ruizhi Wang,…...

1+ week, 5+ day ago  (349+ words) Researchers have identified the molecular trigger behind the rare clotting disorder linked to adenovirus-based COVID-19 vaccines, tracing it to an immune response that mistakenly targets platelet factor 4 (PF4), a normal blood protein involved in clotting. The study addresses vaccine-induced immune thrombocytopenia…...

1+ week, 5+ day ago  (762+ words) When lab tools fail to support interpretation and decision-making, scientists find alternatives Shadow AI has become a defining feature of modern biopharma R&D. Scientists routinely use public AI tools to interpret results, refine protocols, and structure experimental thinking. Much of…...

1+ week, 5+ day ago  (740+ words) The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and Bio NTech streamlines production Pfizer's ELREXFIO improves PFS in Phase 3 multiple myeloma trial Johnson & Johnson has…...

1+ week, 6+ day ago  (415+ words) As regulators move away from animal testing, scalable organoid platforms and standardized i PSC inputs could help close the gap between preclinical models and human biology Over 90 percent of drug candidates that successfully pass animal testing fail in human clinical…...